Background The role of neutrophil–lymphocyte ratio (NLR) as a predictor for survival in
single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear …

Stereotactic Body Radiotherapy has been established as a viable treatment option for
inoperable early-stage Non-Small Cell Lung Cancer or secondary lesions mainly in …

Purpose Data informing the safety, efficacy, treatment logistics, and dosimetry of stereotactic
body radiation therapy (SBRT) for lung tumors has primarily been derived from patients with …

Background: The prevalence of malignant central airway obstruction at diagnosis and its 5-
year incidence are largely unknown, as are basic epidemiological data pertaining to this …

Simple Summary The clinical consequences of irradiating the cardiac substructures during
stereotactic body radiation therapy (SBRT) remains unclear. We evaluated 83 lung cancer …

Simple Summary Stereotactic body radiotherapy for tumors directly touching or overlapping
the trachea, proximal bronchial tree, or esophagus may be a high-risk clinical scenario …

Purpose The objective of this study was to evaluate the incidence of brachial plexus injury
(BPI) after single-fraction stereotactic body radiation therapy (SBRT) to apical lung tumors …

Simple Summary Ablative radiotherapy for central early stage non-small cell lung cancer
(NSCLC) is controversial in its feasibility and optimal dose prescription due to the risk of …

Simple Summary Malignant Central Airway Obstruction (MCAO) is a serious complication of
lung cancer, leading to increased morbidity and mortality. MCAO can present in three major …

Radiotherapy for ultracentral lung tumors represents a treatment challenge, considering the
high rates of high-grade treatment-related toxicities with stereotactic body radiation therapy …